NCT01715129View on ClinicalTrials.gov

Induction and Maintenance of Castration After Subcutaneous Injections of Triptorelin Pamoate in Patients With Prostate Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

126

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions
Prostate Cancer
Interventions
DRUG

Triptorelin Pamoate 11.25mg

Trial Locations (12)

Unknown

Pleven

Plovdiv

Shumen

Varna

Suresnes

Daugavpils

Riga

Kutno

Warsaw

Wroclaw

Bucharest

Craiova

Sponsors

Lead Sponsor

Ipsen
All Listed Sponsors
lead

Ipsen

INDUSTRY